Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Change in Acquisitions & Divestments (2018 - 2019)

Historic Change in Acquisitions & Divestments for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 10 years, with Q4 2019 value amounting to $68000.0.

  • Lifecore Biomedical, Inc. \De\'s Change in Acquisitions & Divestments fell 6512.82% to $68000.0 in Q4 2019 from the same period last year, while for Aug 2020 it was $68000.0, marking a year-over-year decrease of 9191.44%. This contributed to the annual value of $364000.0 for FY2020, which is 3321.1% down from last year.
  • Latest data reveals that Lifecore Biomedical, Inc. \De\ reported Change in Acquisitions & Divestments of $68000.0 as of Q4 2019, which was down 6512.82% from $296000.0 recorded in Q3 2019.
  • Lifecore Biomedical, Inc. \De\'s 5-year Change in Acquisitions & Divestments high stood at $4.4 million for Q1 2015, and its period low was $68000.0 during Q4 2019.
  • In the last 4 years, Lifecore Biomedical, Inc. \De\'s Change in Acquisitions & Divestments had a median value of $221000.0 in 2016 and averaged $813625.0.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first crashed by 9466.09% in 2016, then tumbled by 6512.82% in 2019.
  • Lifecore Biomedical, Inc. \De\'s Change in Acquisitions & Divestments (Quarter) stood at $1.0 million in 2015, then plummeted by 76.77% to $233000.0 in 2016, then decreased by 16.31% to $195000.0 in 2018, then plummeted by 65.13% to $68000.0 in 2019.
  • Its last three reported values are $68000.0 in Q4 2019, $296000.0 for Q3 2019, and $141000.0 during Q2 2019.